Your browser doesn't support javascript.
loading
Utilization and survival outcomes of neoadjuvant chemotherapy for early-stage gastric cancer.
Janczewski, Lauren M; Buchheit, Joanna; Jacobs, Ryan C; Vitello, Dominic; Wells, Amy; Abad, John; Bentrem, David J; Chawla, Akhil.
Affiliation
  • Janczewski LM; Department of Surgery, Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Buchheit J; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Jacobs RC; Department of Surgery, Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Vitello D; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Wells A; Department of Surgery, Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Abad J; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Bentrem DJ; Department of Surgery, Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Chawla A; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
J Surg Oncol ; 130(2): 249-256, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38884323
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Given increased utilization of neoadjuvant therapy (NAT) for gastric adenocarcinoma, practice patterns deviating from standard of care (upfront resection) remain unknown. We sought to identify factors associated with NAT use and survival outcomes among early-stage gastric cancers.

METHODS:

The National Cancer Database identified patients with early-stage (T1N0M0) gastric cancer (2010-2020). Multivariable logistic regression assessed characteristics associated with NAT utilization compared to upfront surgery. After 11 propensity score matching, Kaplan-Meier methods and Cox regression assessed overall survival (OS).

RESULTS:

Of 6452 patients with early-stage gastric cancer, 626 (9.7%) received NAT. Patients who received NAT were more likely treated at community hospitals, had moderate to poorly differentiated disease, and tumors located in the cardia (all p < 0.05). After propensity score matching, 1,248 patients remained. Median OS for NAT was 37.1 months (IQR 20.2-64.0) versus 45.6 months (IQR 22.5-72.8) for resection (p < 0.001). Treatment with NAT remained independently predictive of worse OS on Cox regression (hazard ratio 1.19; 95% confidence interval 1.05-1.34).

CONCLUSIONS:

Although patients who received NAT had more aggressive prognostic features, NAT was associated with worse OS despite accounting for this selection bias. These results highlight the importance of adhering to guidelines, regardless of differing disease characteristics, which has significant implications on outcomes.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Neoadjuvant Therapy Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Surg Oncol Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Neoadjuvant Therapy Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Surg Oncol Year: 2024 Type: Article Affiliation country: United States